Unknown

Dataset Information

0

The antibiotic cyclomarin blocks arginine-phosphate-induced millisecond dynamics in the N-terminal domain of ClpC1 from Mycobacterium tuberculosis.


ABSTRACT: Mycobacterium tuberculosis can remain dormant in the host, an ability that explains the failure of many current tuberculosis treatments. Recently, the natural products cyclomarin, ecumicin, and lassomycin have been shown to efficiently kill Mycobacterium tuberculosis persisters. Their target is the N-terminal domain of the hexameric AAA+ ATPase ClpC1, which recognizes, unfolds, and translocates protein substrates, such as proteins containing phosphorylated arginine residues, to the ClpP1P2 protease for degradation. Surprisingly, these antibiotics do not inhibit ClpC1 ATPase activity, and how they cause cell death is still unclear. Here, using NMR and small-angle X-ray scattering, we demonstrate that arginine-phosphate binding to the ClpC1 N-terminal domain induces millisecond dynamics. We show that these dynamics are caused by conformational changes and do not result from unfolding or oligomerization of this domain. Cyclomarin binding to this domain specifically blocked these N-terminal dynamics. On the basis of these results, we propose a mechanism of action involving cyclomarin-induced restriction of ClpC1 dynamics, which modulates the chaperone enzymatic activity leading eventually to cell death.

SUBMITTER: Weinhaupl K 

PROVIDER: S-EPMC5986217 | biostudies-literature | 2018 Jun

REPOSITORIES: biostudies-literature

altmetric image

Publications

The antibiotic cyclomarin blocks arginine-phosphate-induced millisecond dynamics in the N-terminal domain of ClpC1 from <i>Mycobacterium tuberculosis</i>.

Weinhäupl Katharina K   Brennich Martha M   Kazmaier Uli U   Lelievre Joel J   Ballell Lluis L   Goldberg Alfred A   Schanda Paul P   Fraga Hugo H  

The Journal of biological chemistry 20180409 22


<i>Mycobacterium tuberculosis</i> can remain dormant in the host, an ability that explains the failure of many current tuberculosis treatments. Recently, the natural products cyclomarin, ecumicin, and lassomycin have been shown to efficiently kill <i>Mycobacterium tuberculosis</i> persisters. Their target is the N-terminal domain of the hexameric AAA+ ATPase ClpC1, which recognizes, unfolds, and translocates protein substrates, such as proteins containing phosphorylated arginine residues, to the  ...[more]

Similar Datasets

| S-EPMC6274998 | biostudies-literature
| S-EPMC2631108 | biostudies-literature
| S-EPMC6395927 | biostudies-literature
| S-SCDT-EMM-2020-13207 | biostudies-other
| S-EPMC7799364 | biostudies-literature
| S-EPMC2339742 | biostudies-literature
| S-EPMC4335914 | biostudies-literature
| S-EPMC4416901 | biostudies-literature
| S-EPMC1186028 | biostudies-literature
| S-EPMC6166831 | biostudies-literature